We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

011170:KRXLotte Chemical Corporation Analysis

Data as of 2026-03-16 - not real-time

₩69,100.00

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Lotte Chemical is trading at KRW 69,100, well below its 20‑day (KRW 80,110), 50‑day (KRW 77,122) and 200‑day (KRW 70,034) simple moving averages, indicating a bearish price stance. The RSI of 39.9 and a bearish MACD histogram reinforce short‑term weakness, while volume is on a decreasing trend and 30‑day volatility is high at 91%, suggesting heightened price swings. On the fundamentals side, revenue fell 5.8% YoY, margins are razor‑thin (gross 2.4%, operating –2.8%) and the company posted a –9.3% profit margin, with a negative free cash flow of KRW 719 bn and a debt‑to‑equity ratio of 55, flagging significant financial strain. The dividend payout ratio exceeds 140%, far above earnings, making the 1.45% yield unsustainable, and the DCF fair value of KRW 61,064 is well below the current price, pointing to an overvalued market level.
Given the combination of technical downside, weak profitability, high leverage and an overvalued price relative to intrinsic estimates, the stock presents a high risk profile. Investors should be cautious, as the upside potential is limited while downside risks from earnings deterioration, debt servicing pressures and sector cyclicality remain pronounced.

Market Outlook

Short Term

< 1 year
Cautious
Model confidence: 7/10

Key Factors

  • Price below all major moving averages
  • Bearish MACD and low RSI
  • Decreasing volume and high volatility

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Potential demand recovery in petrochemicals
  • Modest dividend yield but unsustainable payout
  • High debt load limiting flexibility

Long Term

> 3 years
Cautious
Model confidence: 6/10

Key Factors

  • Persistent negative margins and cash flow
  • Elevated debt‑to‑equity ratio
  • Sector cyclicality and regulatory exposure

Key Metrics & Analysis

Financial Health

Revenue Growth-5.80%
Profit Margin-9.33%
P/E Ratio-50.3
ROE-10.40%
ROA-1.33%
Debt/Equity55.04
Op. Cash Flow₩1026.1B
Free Cash Flow₩-719222931456

Technical Analysis

TrendBullish
RSI39.9
Support₩0.00
Resistance₩100,500.00
MA 20₩80,110.00
MA 50₩77,122.00
MA 200₩70,034.50
MACDBearish
VolumeDecreasing
Fear & Greed Index79.45

Valuation

Fair Value₩61,064.64
Target Price₩91,166.66
Upside/Downside31.93%
GradeOvervalued
TypeValue
Dividend Yield1.45%

Risk Assessment

Beta0.33
Volatility91.36%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.